Story thread · 7 reports / 7 sources
Novo Signs Drug Partnership With Orbis Worth Up to $1.4 Billion
bloomberg.com · 4h · first report
How the coverage leans
Across 7 sources · syndicated copies counted once
Novo Nordisk A/S agreed to work with Orbis Medicines ApS on next-generation pills for heart and metabolic diseases in a partnership deal worth as much as $1.4 billion.
The coverage
- Novo pays billions to access Danish pill technology
cphpost.dk · 1h
- Orbis Medicines partners with Novo Nordisk on $1.4bn drug deal
investing.com · 1h
- Novo, Orbis sign up to $1.4 billion deal to develop oral drugs
reuters.com · 2h
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.